Featured Suppliers:
Sponsored Links
AstraZeneca Plc
News and Blogs
Total : 196 View more »
AstraZeneca: Asthma Treatment Gets Approval in Japan
www.pharmaasia.com | Oct 22, 2009
The product will be manufactured and developed by AstraZeneca and distributed and sold by Astellas Pharma, while promotion will be jointly carried out by both companies.
http://www.pharmaasia.com/article-8045-astrazenecaasthmatreatmentgetsapprovalinjapan-asia.html
Drugmaker AstraZeneca See Profits Jump
www.industryweek.com | Oct 29, 2009
Anglo-Swedish pharmaceuticals giant AstraZeneca said on Oct.29 its third-quarter net profit rose 22.3% from the level 12 months ago to $2.115 billion dollars.
http://www.industryweek.com/articles/drugmaker_astrazeneca_see_profits_jump_20285.aspx
AstraZeneca quarterly earns up 22 percent
www.examiner.com | Oct 29, 2009
(AP Photo/Kirsty Wigglesworth, File) FILE - In this Jan. 29, 2009 file photo, reflections are seen on a sign outside the global headquarters of AstraZeneca in London. Pharmaceutical company AstraZeneca PLC reported a 22 percent rise in third quarter net profit on Thursday, Oct. 29.
http://www.examiner.com/a-2293545~AstraZeneca_quarterly_earns_up_22_percent.html?cid=rss-Business
AstraZeneca withdraws cancer drug from regulatory review
www.drugstorenews.com | Oct 28, 2009
AstraZeneca has withdrawn its regulatory approval application for the use of a cancer drug combined with chemotherapy in patients with a form of lung cancer because it didn’t improve patients’ odds of survival, the Anglo-Swedish drug maker announced Wednesday.<img
News from Zibb.com
Total : 94 View more »
Quintiles Transnational announces clinical pharmacology alliance with AstraZeneca - Zibb.com
Nov 03, 2009 (Datamonitor Financial Deals Tracker via COMTEX) --
Quintiles Transnational Corp. has entered into a clinical pharmacology agreement with AstraZeneca plc, a UK-based pharmaceutical company, to deliver AstraZeneca's clinical pharmacology studies across multiple therapy areas and around the globe. Quintiles is a US-based biopharmaceutical services company.
Deal Type Partnership Sub-Category Other Deal Status Announced: 2009-11-02
Deal Participants
Partner 1 (Company) Quintiles Transnational Corp. Partner 2 (Company) AstraZeneca PLC
Tags: clinical partnership pharmaceuticals
Companies: AstraZeneca PLC (AZN)
Research and Markets: AstraZeneca plc 2009 Fortune Global 500 Snapshot Company Profile for those in
Dublin, Nov 03, 2009 (M2 PRESSWIRE via COMTEX) --
Research and Markets(http://www.researchandmarkets.com/research/413ff5/astrazeneca_plc_20) has announced the addition of the "AstraZeneca plc 2009 Fortune Global 500 Snapshot Company Profile" company profile to their offering.
This report provides in-depth company profiles for AstraZeneca plc as ranked in the 2009 Fortune Global 500 list. All data is gathered from primary source. Reports are available in easily accessible PDF format and data is consistently presented. Data is regularly tracked and enhanced to ensure data on these high profile companies is accurate and current. This report is an indispensable tool for investors wanting to gather the relevant facts on the major companies in Asia Pacific. The author concentrates on a small number of high profile companies using tested and trusted research and editorial methodologies.
Countries Covered
United Kingdom
Key Topics Covered:
This report provides the following corporate data where available:-
- Company Name
- Company Variant Name
- Address
- Primary Telephone Number
- Primary Fax Number
- Website
- SIC Codes
- Date of Establishment
- Stock Exchange and Ticker
- Competitors
- Activities Description
- Board of Directors
- Senior Management and Key Decision Makers
- Executive Biographies
- Selected Financial Data covering 8 Years (Sales, PBT, PAT, Shareholders' Equity, Total Assets, EPS and Dividends)
- Analyst Coverage
- Trade Names
- Locations
For more information visit http://www.researchandmarkets.com/research/413ff5/astrazeneca_plc_20
CONTACT: Laura Wood, Senior Manager, Research and Markets Fax: +1 646 607 1907 (from USA) Fax: +353 1 481 1716 (rest of the world) e-mail: press@researchandmarkets.com
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
Tags: asia dividends email e-mail eps equity executive investment opinion medical research sales trade united kingdom web
Companies: AstraZeneca PLC (AZN)
AstraZeneca PLC (ADR) (AZN) Corporate Event Announcement Notice - Zibb.com
Oct 27, 2009 (Wall Street Horizon via COMTEX) --
AstraZeneca PLC (ADR) (AZN)
Expected next earnings release: Announcement date: 10/29/2009 - Before Market Earnings Quarter: Q3 Announcement Status: Verified
Expected next investor conference call information: Conference Call Date: 10/29/2009 Conference Call Time (ET): 9:00 AM Conference Call URL:
Tags: conference corporate earnings market
Companies: AstraZeneca PLC (AZN)
AstraZeneca PLC (ADR) (AZN) Corporate Event Announcement Notice - Zibb.com
Oct 29, 2009 (Wall Street Horizon via COMTEX) --
AstraZeneca PLC (ADR) (AZN)
Expected next earnings release: Announcement date: 10/29/2009 - Before Market Earnings Quarter: Q3 Announcement Status: Verified
Expected next investor conference call information: Conference Call Date: 10/29/2009 Conference Call Time (ET): 9:00 AM Conference Call URL:
Tags: conference corporate earnings market
Companies: AstraZeneca PLC (AZN)
Web Sites
Total : 2,554 View more »
Mark E. Haddad, with whom Nitin Reddy, Carter G. Phillips, Sidley Austin LLP, D. Scott Wise,...
www.ca1.uscourts.gov
Mark E. Haddad, with whom Nitin Reddy, Carter G. Phillips, Sidley Austin LLP, D. Scott Wise, Michael S. Flynn, Kimberley D. Harris, Davis Polk & Wardwell, Donald R. Ware, Sarah Cooleybeck and Foley Hoag LLP, were on brief for appellant. Steve W. Berman, with whom Sean R.
AstraZeneca International - pharmaceutical company - prescription drugs - medicine manufacturers
Welcome to AstraZeneca's international website. As one of the world's leading pharmaceutical companies, our business is focused on turning good ideas into innovative, effective medicines that make a real difference in important areas of healthcare.
ScienceDirect - Drug Discovery Today: Therapeutic Strategies, Volume 5, Issue 2, Pages 79-142
www.sciencedirect.com
ScienceDirect - the world's leading platform offers over 2,000 high quality peer-reviewed full-text journals and books on science, technology and medicine.
AstraZeneca Accepts Secretary of Defense Award for Supporting Employees Serving in National Guard and Reserve
www.bio-medicine.org
Health,... ... ...WILMINGTON Del. Sept. 17 /- AstraZeneca (NYSE... ...,AstraZeneca,Accepts,Secretary,of,Defense,Award,for,Supporting,Employees,Serving,in,National,Guard,and,Reserve,medicine,medical news today,latest medical news,medical newsletters,current medical news,latest medicine news
Web Sites
powered by 
Total : 1,570,000 View more »
AstraZeneca International - pharmaceutical company - prescription ...
www.astrazeneca.com
29 October 2009 AstraZeneca PLC Third Quarter & Nine Months Results 2009 Strong business performance has been driven by good operating execution bolstered by revenue upsides ...
AstraZeneca Pharmaceuticals - U.S. Home Page
astrazeneca-us.com
Welcome to AstraZeneca in the United States As one of the world's leading ... Oct 29, 2009 AstraZeneca PLC third quarter and nine months results 2009
AstraZeneca - Wikipedia, the free encyclopedia
en.wikipedia.org
AstraZeneca plc [1] (LSE: AZN, NYSE: AZN, OMX: AZN) is an Anglo-Swedish pharmaceutical company formed on 6 April 1999 by the re merger of Swedish Astra AB and British Zeneca Group ...
AstraZeneca United Kingdom
www.astrazeneca.co.uk
Develops new medicines, includes news releases and careers section for new college graduates. Headquarters and main research centres are located around the UK.
News from Zibb.com
- Quintiles Transnational announces clinical pharmacology alliance with AstraZeneca - Zibb.com
- Research and Markets: AstraZeneca plc 2009 Fortune Global 500 Snapshot Company Profile for those in
- AstraZeneca PLC (ADR) (AZN) Corporate Event Announcement Notice - Zibb.com
- AstraZeneca PLC (ADR) (AZN) Corporate Event Announcement Notice - Zibb.com
Explore Related Topics
Explore Related Products
Events
Pharmaceutical Event: : PharmiWeb
Navigation [accesskey 1] Content [accesskey 2] Site Search [accesskey 3] Job Seekers Login [accesskey 4] top of page [accesskey 5] PharmiWeb.com, From PharmiWeb Solutions PharmiWeb.com from PharmiWeb Solutions PharmiWeb.com Home Page 19 June 2008 Select a company 1st Pharma People 20:20 Selection
http://www.pharmiweb.com/events/event.asp?eventId=4133&channel=2
Irish Medical Times | Gallery
www.imt.ie
Pictured are some of the attendees of a presentation by the 'father of modern contraception' - Prof John Guillbaud - which took place at the Herbert Park Hotel in Ballsbridge, Dublin
Effective Marketing and PR Strategies for Patient Recruitment in Clinical Trials - SMi Group -
With clinical trials running over budget and with too few participants, this executive briefing in association with Roche and AstraZeneca promises to provide invaluable advice on producing effective marketing strategies to attract and retain patients.
http://www.smi-online.co.uk/event_media/overview.asp?is=4&ref=2642
Society of Chemical Industry: Events
G-protein-coupled receptors (GPCRs) play a crucial role in transmitting chemical signals from hormones and neurotransmitters across cell membranes and converting them into cellular responses.